EQT nears deal to acquire pharma services firm Certara: Reuters
Private equity firm EQT is nearing a deal to acquire U.S. drug development consultancy Certara for around $850 million, including debt, from Arsenal Capital Partners, another buyout firm, Reuters reported.





